News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
739,921 Results
Type
Article (41804)
Company Profile (306)
Press Release (697798)
Multimedia
Podcasts (93)
Webinars (20)
Section
Business (207243)
Career Advice (2046)
Deals (35913)
Drug Delivery (131)
Drug Development (82615)
Employer Resources (175)
FDA (16562)
Job Trends (15124)
News (350737)
Policy (32956)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2607)
Accelerated approval (51)
Adcomms (27)
Allergies (174)
Alliances (50234)
ALS (215)
Alzheimer's disease (1813)
Antibody-drug conjugate (ADC) (476)
Approvals (16981)
Artificial intelligence (683)
Autoimmune disease (313)
Automation (58)
Bankruptcy (362)
Best Places to Work (11736)
BIOSECURE Act (20)
Biosimilars (228)
Biotechnology (201)
Bladder cancer (200)
Brain cancer (74)
Breast cancer (776)
Cancer (6001)
Cardiovascular disease (495)
Career advice (1737)
Career pathing (43)
CAR-T (338)
CDC (57)
Celiac Disease (3)
Cell therapy (924)
Cervical cancer (49)
Clinical research (71925)
Collaboration (2124)
Company closure (5)
Compensation (1430)
Complete response letters (80)
COVID-19 (2758)
CRISPR (109)
C-suite (1171)
Cystic fibrosis (156)
Data (8181)
Decentralized trials (3)
Denatured (28)
Depression (167)
Dermatology (91)
Diabetes (600)
Diagnostics (6974)
Digital health (56)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (332)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (290)
Earnings (93111)
Editorial (67)
Employer branding (22)
Employer resources (154)
Events (122172)
Executive appointments (1108)
FDA (20376)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1754)
Gene editing (236)
Generative AI (56)
Gene therapy (730)
GLP-1 (1072)
Government (4753)
Grass and pollen (7)
Guidances (411)
Healthcare (19138)
HIV (82)
Huntington's disease (56)
IgA nephropathy (101)
Immunology and inflammation (292)
Immuno-oncology (98)
Indications (198)
Infectious disease (3109)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (298)
Interviews (323)
IPO (16856)
IRA (50)
Job creations (3694)
Job search strategy (1440)
JPM (58)
Kidney cancer (19)
Labor market (104)
Layoffs (569)
Leadership (40)
Legal (7980)
Liver cancer (102)
Longevity (34)
Lung cancer (791)
Lymphoma (441)
Machine learning (61)
Management (59)
Manufacturing (1078)
MASH (205)
Medical device (13959)
Medtech (14091)
Mergers & acquisitions (20328)
Metabolic disorders (1544)
mRNA (212)
Multiple sclerosis (195)
NASH (17)
Neurodegenerative disease (432)
Neuropsychiatric disorders (106)
Neuroscience (3371)
Neurotech (1)
NextGen: Class of 2026 (6548)
Non-profit (4547)
Now hiring (79)
Obesity (714)
Opinion (289)
Ovarian cancer (230)
Pain (260)
Pancreatic cancer (312)
Parkinson's disease (377)
Partnered (33)
Patents (608)
Patient recruitment (701)
Peanut (62)
People (60381)
Pharmaceutical (69)
Pharmacy benefit managers (33)
Phase 1 (22456)
Phase 2 (31738)
Phase 3 (23481)
Pipeline (9108)
Policy (321)
Postmarket research (2575)
Preclinical (9570)
Press Release (64)
Prostate cancer (314)
Psychedelics (54)
Radiopharmaceuticals (344)
Rare diseases (1096)
Real estate (6061)
Recruiting (71)
Regulatory (25696)
Reports (56)
Research institute (2430)
Resumes & cover letters (353)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (181)
Series A (291)
Series B (215)
Service/supplier (11)
Sickle cell disease (112)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3688)
State (2)
Stomach cancer (18)
Supply chain (129)
Tariffs (87)
The Weekly (63)
Vaccines (1118)
Venture capital (113)
Weight loss (456)
Women's health (128)
Worklife (20)
Date
Last 7 days (612)
Last 30 days (3150)
Last 365 days (30313)
2026 (13811)
2025 (30426)
2024 (35553)
2023 (40469)
2022 (51632)
2021 (56240)
2020 (54467)
2019 (46895)
2018 (35310)
2017 (32504)
2016 (31946)
2015 (38016)
2014 (31842)
2013 (26766)
2012 (28940)
2011 (29608)
2010 (27666)
Location
Africa (751)
Alabama (98)
Alaska (7)
Arizona (353)
Arkansas (15)
Asia (40742)
Australia (6632)
California (13572)
Canada (3840)
China (1424)
Colorado (579)
Connecticut (590)
Delaware (416)
Europe (88906)
Florida (2051)
Georgia (434)
Hawaii (3)
Idaho (63)
Illinois (1081)
India (93)
Indiana (613)
Iowa (23)
Japan (556)
Kansas (131)
Kentucky (50)
Louisiana (45)
Maine (76)
Maryland (1624)
Massachusetts (9751)
Michigan (370)
Minnesota (734)
Mississippi (6)
Missouri (145)
Montana (33)
Nebraska (29)
Nevada (145)
New Hampshire (84)
New Jersey (3569)
New Mexico (30)
New York (3568)
North Carolina (1776)
North Dakota (9)
Northern California (6830)
Ohio (404)
Oklahoma (23)
Oregon (42)
Pennsylvania (2717)
Puerto Rico (30)
Rhode Island (50)
South America (1125)
South Carolina (86)
South Dakota (2)
Southern California (5351)
Tennessee (215)
Texas (2160)
United States (48018)
Utah (402)
Vermont (1)
Virginia (329)
Washington D.C. (81)
Washington State (1101)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
739,921 Results for "regenerx biopharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Servier completes the acquisition of Day One Biopharmaceuticals
April 23, 2026
·
2 min read
Press Releases
Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
May 27, 2026
·
9 min read
Press Releases
Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
May 19, 2026
·
7 min read
Press Releases
XTL Biopharmaceuticals Announces ADS Ratio Change
March 23, 2026
·
4 min read
Press Releases
Sparrow Appoints Biopharmaceutical Industry Veteran, Carlo Incerti, M.D. to its Board of Directors
February 2, 2026
·
3 min read
Press Releases
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
April 20, 2026
·
3 min read
BioCapital
RegeneRx To Extend Consent Solicitation Vote
RegeneRx Biopharmaceuticals, Inc. announced that, pursuant to the company’s consent solicitation dated July 11, 2023, holders of 48.5% of the Company’s outstanding stock have voted to date, with 94% voting in favor of the proposed reverse stock split.
August 1, 2023
·
2 min read
Press Releases
Sino Biological ProPure™ Endotoxin-Free Proteins: The “Invisible Guardian” of Biopharmaceuticals
April 1, 2026
·
2 min read
Press Releases
Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors
April 6, 2026
·
4 min read
Press Releases
BioPhorum relaunches expanded Host Cell Protein Data Platform to support safer biopharmaceutical development
The upgraded platform offers a searchable database of over 300 risk-assessed HCPs, automated research scanning, and new flexible pricing options for mid-size drug developers.
May 26, 2026
·
1 min read
1 of 73,993
Next
